Mechanistic and biological characterisation of novel N⁵-substituted paullones targeting the biosynthesis of trypanothione in Leishmania

References

• Fairlamb AH, Blackburn P, Ulrich P, et al. Trypanothione: a novel bis(glutathionyl)spermidine cofactor for glutathione reductase in trypanosomatids. Science 1985;227:1485–7.
   PubMed Web of Science ®Google Scholar
• Krauth-Siegel RL, Comini M. Redox control in trypanosomatids, parasitic protozoa with trypanothione-based thiol metabolism. Biochim Biophys Acta 2008;1780:1236–48.
   PubMed Web of Science ®Google Scholar
• Manta B, Bonilla M, Fiestas L, et al. Polyamine-based thiols in trypanosomatids: evolution, protein structural adaptations, and biological functions. Antioxid Redox Signal 2018;28:463–86.
   PubMed Web of Science ®Google Scholar
• Croft SL, Sundar S, Fairlamb AH. Drug resistance in leishmaniasis. Clin Microbiol Rev 2006;19:111–26.
   PubMed Web of Science ®Google Scholar
• Franco J, Scarone L, Comini MA. Drugs and drug resistance in African and American trypanosomiasis. Annu Rep Med Chem 2018;51:97–133.
   Web of Science ®Google Scholar
• Ghosh AK, Saini S, Das S, et al. Glucose-6-phosphate dehydrogenase and Trypanothione reductase interaction protects Leishmania donovani from metalloid mediated oxidative stress. Free Radic Biol Med 2017;106:10–23.
   PubMed Web of Science ®Google Scholar
• Pountain AW, Barrett MP. Untargeted metabolomics to understand the basis of phenotypic differences in amphotericin B-resistant Leishmania parasites. Wellcome Open Res 2019;4:176.
   PubMedGoogle Scholar
• Comini M, Guerrero SA, Haile S, et al. Validation of Trypanosoma brucei trypanothione synthetase as drug target. Free Radic Biol Med 2004;36:1289–302.
   PubMed Web of Science ®Google Scholar
• Wyllie S, Oza SL, Patterson S, et al. Dissecting the essentiality of the bifunctional trypanothione synthetase-amidase in Trypanosoma brucei using chemical and genetic methods. Mol Microbiol 2009;74:529–40.
   PubMed Web of Science ®Google Scholar
• Sousa AF, Gomes-Alves AG, Benítez D, et al. Genetic and chemical analyses reveal that trypanothione synthetase but not glutathionylspermidine synthetase is essential for Leishmania infantum . Free Radic Biol Med 2014;73:229–38.
   PubMed Web of Science ®Google Scholar
• Mesías AC, Sasoni N, Arias DG, et al. Trypanothione synthetase confers growth, survival advantage and resistance to anti-protozoal drugs in Trypanosoma cruzi. Free Radic Biol Med 2019;130:23–34.
   PubMed Web of Science ®Google Scholar
• Leroux AE, Krauth-Siegel RL. Thiol redox biology of trypanosomatids and potential targets for chemotherapy. Mol Biochem Parasitol 2016;206:67–74.
   PubMed Web of Science ®Google Scholar
• D’Silva C, Daunes S, Rock P, et al. Structure-activity study on the in vitro antiprotozoal activity of glutathione derivatives. J Med Chem 2000;43:2072–8.
   PubMed Web of Science ®Google Scholar
• Oza SL, Chen S, Wyllie S, et al. ATP-dependent ligases in trypanothione biosynthesis-kinetics of catalysis and inhibition by phosphinic acid pseudopeptides. Febs J 2008;275:5408–21.
   PubMed Web of Science ®Google Scholar
• Saudagar P, Dubey VK. Cloning, expression, characterization and inhibition studies on trypanothione synthetase, a drug target enzyme, from Leishmania donovani. Biol Chem 2011;392:1113–22.
   PubMed Web of Science ®Google Scholar
• Zimmermann S, Oufir M, Leroux A, et al. Cynaropicrin targets the trypanothione redox system in Trypanosoma brucei. Bioorg Med Chem 2013;21:7202–9.
   PubMed Web of Science ®Google Scholar
• Torrie LS, Wyllie S, Spinks D, et al. Chemical validation of trypanothione synthetase a potential drug target for human trypanosomiasis. J Biol Chem 2009;284:36137–45.
   PubMed Web of Science ®Google Scholar
• Spinks D, Torrie LS, Thompson S, et al. Design, synthesis and biological evaluation of Trypanosoma brucei trypanothione synthetase inhibitors. *ChemMedChem 2012;7:95–106.
   PubMed Web of Science ®Google Scholar
• Saudagar P, Saha P, Saikia AK, Dubey VK. Molecular mechanism underlying antileishmanial effect of oxabicyclo[3.3.1]nonanones: inhibition of key redox enzymes of the pathogen. Eur J Pharm Biopharm 2013;85:569–77.
   PubMed Web of Science ®Google Scholar
• Benítez D, Medeiros A, Fiestas L, et al. Identification of novel chemical scaffolds inhibiting trypanothione synthetase from pathogenic trypanosomatids. PLoS Negl Trop Dis 2016;10:e0004617.
   PubMed Web of Science ®Google Scholar
• Orban OC, Korn RS, Benítez D, et al. 5-Substituted 3-chlorokenpaullone derivatives are potent inhibitors of Trypanosoma brucei bloodstream forms. Bioorg Med Chem 2016;24:3790–800.
   PubMed Web of Science ®Google Scholar
• Kunick C, Lauenroth K, Wieking K, et al. Evaluation and comparison of 3D-QSAR CoMSIA models for CDK1, CDK5, and GSK-3 inhibition by paullones. J Med Chem 2004;47:22–36.
   PubMed Web of Science ®Google Scholar
• Orban OCF, Korn RS, Unger L, et al. Chlorokenpaullone. Molbank 2015;2015:M856.
   Google Scholar
• Jo MN, Seo HJ, Kim Y, et al. Novel T-type calcium channel blockers: dioxoquinazoline carboxamide derivatives. Bioorg Med Chem 2007;15:365–73.
   PubMed Web of Science ®Google Scholar
• Ascenzi P, Ascenzi MG, Amiconi G. Enzyme competitive inhibition. Graphical determination of Ki and presentation of data in comparative studies. Biochem Educ 1987;15:134–5.
   Google Scholar
• Keller S, Vargas C, Zhao H, et al. High-precision isothermal titration calorimetry with automated peak-shape analysis. Anal Chem 2012;84:5066–73.
   PubMed Web of Science ®Google Scholar
• Scheuermann T, Brautigam C. High-precision, automated integration of multiple isothermal titration calorimetric thermograms: new features of NITPIC. Methods 2015;76:87–98.
   PubMed Web of Science ®Google Scholar
• Houtman JC, Brown PH, Bowden B, et al. Studying multisite binary and ternary protein interactions by global analysis of isothermal titration calorimetry data in SEDPHAT: application to adaptor protein complexes in cell signaling. Protein Sci 2007;16:30–42.
   PubMed Web of Science ®Google Scholar
• Brautigam CA. Calculations and publication-quality illustrations for analytical ultracentrifugation data. Meth Enzymol 2015;562:109–34.
   PubMed Web of Science ®Google Scholar
• Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 2010;31:455–61.
   PubMed Web of Science ®Google Scholar
• Morris GM, Huey R, Lindstrom W, et al. Autodock4 and AutoDockTools4: automated docking with selective receptor flexiblity. J Comput Chem 2009;30:2785–91.
   PubMed Web of Science ®Google Scholar
• Fiser A, Sali A. ModLoop: automated modeling of loops in protein structures. Bioinformatics 2003;19:2500–1.
   PubMed Web of Science ®Google Scholar
• Sievers F, Wilm A, Dineen D, et al. Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol Syst Biol 2011;7:539.
   PubMed Web of Science ®Google Scholar
• Edelstein AD, Tsuchida MA, Amodaj N, et al. Advanced methods of microscope control using µManager software. J Biol Methods 2014;1:e11.
   Google Scholar
• Fairlamb AH, Henderson GB, Bacchi CJ, Cerami A. In vivo effects of difluoromethylornithine on trypanothione and polyamine levels in bloodstream forms of Trypanosoma brucei. Mol Biochem Parasitol 1987;24:185–91.
   PubMed Web of Science ®Google Scholar
• Pai CH, Chiang BY, Ko TP, et al. Dual binding sites for translocation catalysis by Escherichia coli glutathionylspermidine synthetase. Embo J 2006;25:5970–82.
   PubMed Web of Science ®Google Scholar
• Oza SL, Tetaud E, Ariyanayagam MR, et al. A single enzyme catalyses formation of trypanothione from glutathione and spermidine in Trypanosoma cruzi. J Biol Chem 2002;277:35853–61.
   PubMed Web of Science ®Google Scholar
• Fyfe PK, Oza SL, Fairlamb AH, Hunter WN. Leishmania trypanothione synthetase-amidase structure reveals a basis for regulation of conflicting synthetic and hydrolytic activities. J Biol Chem 2008;283:17672–80.
   PubMed Web of Science ®Google Scholar
• Koch O, Cappel D, Nocker M, et al. Molecular dynamics reveal binding mode of glutathionylspermidine by trypanothione synthetase. PLoS One 2013;8:e56788.
   PubMed Web of Science ®Google Scholar
• Comini M, Menge U, Wissing J, Flohé L. Trypanothione synthesis in Crithidia revisited. J Biol Chem 2005;280:6850–60.
   PubMed Web of Science ®Google Scholar
• Jäger T, Koch O, Flohé L, Selzer PM, (Eds.). Trypanosomatid diseases: molecular routes to drug discovery (Drug Discovery in Infectious Diseases). Oxford, UK: Wiley-Blackwell; 2013.*
   Google Scholar
• Burza S, Croft SL, Boelaert M. Leishmaniasis. Lancet 2018;392:951–70.
   PubMed Web of Science ®Google Scholar
• Schultz C, Link A, Leost M, et al. Paullones, a series of cyclin-dependent kinase inhibitors: synthesis, evaluation of CDK1/cyclin B inhibition, and in vitro antitumor activity. J Med Chem 1999;42:2909–19.
   PubMed Web of Science ®Google Scholar
• Zaharevitz DW, Gussio R, Leost M, et al. Discovery and initial characterization of the paullones, a novel class of small-molecule inhibitors of cyclin-dependent kinases. Cancer Res 1999;59:2566–9.
   PubMed Web of Science ®Google Scholar
• Bain J, Plater L, Elliott M, et al. The selectivity of protein kinase inhibitors: a further update. Biochem J 2007;408:297–315.
   PubMed Web of Science ®Google Scholar
• Egert-Schmidt AM, Dreher J, Dunkel U, et al. Identification of 2-anilino-9-methoxy-5,7-dihydro-6H-pyrimido[5,4-d][1]benzazepin-6-ones as dual PLK1/VEGF-R2 kinase inhibitor chemotypes by structure-based lead generation. J Med Chem 2010;53:2433–42.
   PubMed Web of Science ®Google Scholar
• Lyssiotis CA, Foreman RK, Staerk J, et al. Reprogramming of murine fibroblasts to induced pluripotent stem cells with chemical complementation of Klf4. Proc Natl Acad Sci USA 2009;106:8912–7.
   PubMed Web of Science ®Google Scholar
• Stukenbrock H, Mussmann R, Geese M, et al. 9-Cyano-1-azapaullone (cazpaullone), a glycogen synthase kinase-3 (GSK-3) inhibitor activating pancreatic beta cell protection and replication. J Med Chem 2008;51:2196–207.
   PubMed Web of Science ®Google Scholar
• Tolle N, Kunick C. Paullones as inhibitors of protein kinases. Curr Top Med Chem 2011;11(11):1320–32.
   PubMed Web of Science ®Google Scholar
• Bertrand JA, Thieffine S, Vulpetti A, et al. Structural characterization of the GSK-3beta active site using selective and non-selective ATP-mimetic inhibitors. J Mol Biol 2003;333:393–407.
   PubMed Web of Science ®Google Scholar
• Cornish-Bowden A. Why is uncompetitive inhibition so rare? A possible explanation, with implications for the design of drugs and pesticides. FEBS Lett 1986;203:3–6.
   PubMed Web of Science ®Google Scholar